HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Treatment of cholecystitis: cholecystostomy or cholecystectomy?

Abstract
Nine hundred ninety-two consecutive patients with cholelithiasis and cholecystitis are reported on. In Finland, these diseases seem to affect women more often than men as only 18% in the present series were men. The frequency of these diseases increases with advancing age and reaches its peak in patients sixty to sixty-five years of age. Therapy always consisted of cholecystectomy. The incidence of minor technical complications varied from 1.1% in group I to 4.5% in group III (6.1% in group IIB). Postoperative nonfatal complications varied from 2.0% in group I to 5.2% in group III (8.1% in group IIB). The age-adjusted duration of postoperative hospitalization was about eight days (in group IIB, nine days. In groups I and II one patient died whereas in group III two died. The mortality varied from 0.2% in group I to 0.6% in group III (1.2% in group IIB). The overall mortality for this series was 0.5%. On the basis of this analysis and the good results, I have concluded that cholecystectomy is the preferred therapy for cholecystitis at all stages when all coexisting diseases and water and elctrolyte imbalances have been treated.
AuthorsE E Vuori
JournalAmerican journal of surgery (Am J Surg) Vol. 132 Issue 1 Pg. 75-80 (Jul 1976) ISSN: 0002-9610 [Print] United States
PMID952339 (Publication Type: Journal Article)
Topics
  • Adolescent
  • Adult
  • Age Factors
  • Aged
  • Cholecystectomy (mortality)
  • Cholecystitis (surgery)
  • Cholelithiasis (epidemiology, surgery)
  • Drainage
  • Female
  • Finland
  • Gallbladder (surgery)
  • Humans
  • Male
  • Middle Aged
  • Postoperative Complications

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: